Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 1—January 2007

Research

Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England

Cheryl Cohen*1Comments to Author , Joanne M. White†, Emma J. Savage†, Judith R. Glynn*, Yoon Choi†, Nick Andrews†, David Brown†, and Mary E. Ramsay†
Author affiliations: *London School of Hygiene and Tropical Medicine, London, United Kingdom; †Health Protection Agency Centre for Infections, London, United Kingdom; 1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa

Main Article

Table 3

Age-specific estimates of vaccine effectiveness for 1 and 2 doses of measles, mumps, rubella vaccine

Age group, yEffectiveness
1 dose, % (95% CI*)2 doses, % (95% CI*)
295.9 (81.1–99.1)
5–693.8 (84.1–97.6)98.8 (97.0–99.5)
7–890.3 (81.2–95.0)95.8 (92.9–97.5)
9–1086.5 (75.3–92.6)92.4 (87.7–95.3)
11–1265.9 (30.3–83.3)86.4 (74.1–92.9)

*CI, confidence interval; p for linear trend <0.001 for 1 and 2 doses.

Main Article

1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa

TOP